Elbogen

MUFG hires Robert Ellenbogen as senior credit analyst to enhance leveraged finance platform

Retrieved on: 
Monday, March 20, 2023
Mitsubishi UFJ Financial Group, MUFG, Mitsubishi Group, NYSE, Credit Suisse, Elbogen, Cryptocurrency, Financial services

NEW YORK, March 20, 2023 /PRNewswire/ -- Mitsubishi UFJ Financial Group (MUFG's) (NYSE: MUFG) announced today that it has hired Robert Ellenbogen to its Leveraged Finance team as a Managing Director and Senior Credit Analyst.

Key Points: 
  • NEW YORK, March 20, 2023 /PRNewswire/ -- Mitsubishi UFJ Financial Group ( MUFG 's) (NYSE: MUFG ) announced today that it has hired Robert Ellenbogen to its Leveraged Finance team as a Managing Director and Senior Credit Analyst.
  • Ellenbogen will be responsible for delivering industry and company-specific analysis to MUFG's Leveraged Finance Platform in support of deal origination, sales and trading, and investor connectivity, with a focus on the energy sector.
  • Joining MUFG on March 20, 2023, he will be based in New York and report to Todd Bondy, Head of Leveraged Trading.
  • Ellenbogen joins MUFG from Credit Suisse, where he was a Managing Director and High-Yield Strategist, and before then was part of their Leveraged Finance Origination and Restructuring group.

Medtronic First to Receive FDA Approval for Pacing the Heart's Natural Conduction System

Retrieved on: 
Monday, October 17, 2022
Physician, LinkedIn, U.S. Securities and Exchange Commission, 3830, NYSE, Bradycardia, Patient, AV, SK, Twitter, Security (finance), Elbogen, MDT, Electrophysiology, Food, Systematic review, Food and Drug Administration, Health, Nissan Micra, Pain, Atrioventricular block, Wilkes-Barre, Pennsylvania, Meta-analysis, FDA, Solution, Medical device, Medical imaging, Medtronic

DUBLIN, Oct. 17, 2022 /PRNewswire/ -- Medtronic plc (NYSE: MDT) today announced it has received U.S. Food and Drug Administration (FDA) approval for expanded labeling of a cardiac lead that taps into the heart's natural electrical system, giving patients needed therapy while avoiding complications sometimes associated with traditional pacing methods, such as cardiomyopathy.1 Commonly referred to as "conduction system pacing," this approach helps ensure that pacing closely mimics the heart's physiologic contractions, allowing the heart's ventricles to work in coordination.1

Key Points: 
  • In 2018, the FDA approved the SelectSecure MRI SureScan Model 3830 cardiac lead for His-Bundle pacing, another form of conduction system pacing.
  • Now this cardiac lead is approved for pacing and sensing at the bundle of His or in the left bundle branch area as an alternative to apical pacing in the right ventricle in a single- or dual-chamber pacing system.
  • This new approval adds to the Medtronic legacy of cardiac pacing innovative "firsts," which include:
    The first leadless pacemaker (the Micra Transcatheter Pacing System, launched in 2016 and expanded to patients with AV block in 2020)
    The first wearable pacemaker invented by Medtronic founder Earl Bakken in 1957.
  • "Expanded labeling of this lead allows us to train physicians to successfully perform left bundle procedures, bringing the benefits of conduction system pacing to more patients."

WILDBRAIN RENEWS CEO ERIC ELLENBOGEN'S CONTRACT

Retrieved on: 
Wednesday, August 24, 2022
COVID-19, WildBrain Spark, CEO, Rights, The Snoopy Show, Risk, Toronto Stock Exchange, Culture, Roku, Forward-looking statement, Apple TV, Board of directors, Company, IP, SEDAR, 21st Century Fox, Amazon, Marvel Entertainment, Sale, Board, AVOD, Pappas Telecasting, Sonic the Hedgehog, ByteDance, Strawberry Shortcake, Partnership, Rocky, DreamWorks Animation, Western Publishing, DreamWorks, DWA, SEGA, Investment, WildBrain CPLG, Jay Ward Productions, Hedgehog, NS, Acquisition, Growth, Marketing, Elbogen, YouTube, Netflix, IQIYI, TSX, NBCUniversal, The Adventures of Rocky and Bullwinkle and Friends, DreamWorks Classics, Contract, Family, Management, Video game, Video game console, Publishing, Renewable energy, Risk management, Teletubbies, WildBrain, BC, Nickelodeon, Hasbro, The Walt Disney Company

HALIFAX, NS, Aug. 24, 2022 /PRNewswire/ - The Board of Directors of WildBrain Ltd. ("WildBrain" or the "Company") (TSX: WILD), a global leader in kids' and family entertainment, has extended Eric Ellenbogen's contract as Chief Executive Officer and Vice Chair of the Company for three years.

Key Points: 
  • HALIFAX, NS, Aug. 24, 2022 /PRNewswire/ - The Board of Directors of WildBrain Ltd. ("WildBrain" or the "Company") (TSX: WILD), a global leader in kids' and family entertainment, has extended Eric Ellenbogen's contract as Chief Executive Officer and Vice Chair of the Company for three years.
  • Ellenbogen joined WildBrain in August 2019 and, since then, has bolstered the Company's core businesses, while opening new growth areas and expanding into new regions.
  • Don Wright, Chair of WildBrain's Board of Directors, said: "When Eric was appointed CEO and Vice Chair almost three years ago, WildBrain needed a new vision and a turnaround.
  • Although WildBrain believes that the expectations reflected in such forward looking statements are reasonable, such statements involve risks and uncertainties and are based on information currently available to WildBrain.

EBR Systems’ WiSE CRT System Demonstrates Technical Feasibility of Leadless Left Bundle Branch Area Pacing for Cardiac Resynchronization

Retrieved on: 
Wednesday, October 27, 2021
Cardiology, Biotechnology, Medical Supplies, Hardware, Health, Medical Devices, Technology, Other Health, Coronary sinus, Technology, CHU, Cardiac resynchronization therapy, Bradycardia, CRT, ECG, EBR, Nasal septum, European Heart Journal, LV, CEO, Silicon, Atrioventricular block, Male, Hope, Wireless, Heart failure, Wise, Heart, Elbogen, Sale, Medical device

EBR Systems, Inc. , developer of the worlds only wireless cardiac pacing system for heart failure, today announced the publication of a case report demonstrating the WiSE CRT Systems ability to successfully deliver leadless Left Bundle Branch Area Pacing (LBBAP).

Key Points: 
  • EBR Systems, Inc. , developer of the worlds only wireless cardiac pacing system for heart failure, today announced the publication of a case report demonstrating the WiSE CRT Systems ability to successfully deliver leadless Left Bundle Branch Area Pacing (LBBAP).
  • WiSE is the only leadless pacing technology able to achieve LBBAP, a novel form of conduction system pacing which can reverse left bundle branch block and deliver cardiac resynchronization therapy (CRT).
  • WiSE is the first and only leadless pacing system that can deliver physiologic, conduction system pacing without leads.
  • Cardiac Resynchronization Therapy by Left Bundle Branch Area Pacing in Patients with Heart Failure and Left Bundle Branch Block.

Henry Ellenbogen's Durable Capital Partners LP Makes First Investment in Fast-Growing Fintech-as-a-Service Provider Rapyd

Retrieved on: 
Tuesday, December 3, 2019
Elbogen

HALF MOON BAY, Calif., Dec. 3, 2019 /PRNewswire/ -- Rapyd , a global Fintech-as-a-service provider today announced that Durable Capital Partners LP, has made its first investment in Rapyd.

Key Points: 
  • HALF MOON BAY, Calif., Dec. 3, 2019 /PRNewswire/ -- Rapyd , a global Fintech-as-a-service provider today announced that Durable Capital Partners LP, has made its first investment in Rapyd.
  • Durable Capital Partners LP seeks to identify and invest in early stage growth companies in high growth technology sectors.
  • Arik Shtilman, CEO of Rapyd, commented, "We are thrilled that Durable Capital Partners LP under the leadership of Henry Ellenbogen is making its first investment in Rapyd.
  • Durable Capital Partners LP is a newly formed investment adviser founded by Henry Ellenbogen.